MADISON, Wis.--(BUSINESS WIRE)--Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from ...
Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...
Developing an efficient vaccine against HIV-1 includes the identification of a target (antigen) that will elicit an antibody response mediating antibody-dependent cellular cytotoxicity (ADCC) because ...
An advanced computerized decision support technology to support breast multidisciplinary meetings. The influence of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in ...
Inflammatory breast cancer (IBC) is the deadliest, distinct subtype of breast cancer. High expression of epidermal growth factor receptors [EGFR or human epidermal growth factor receptor 2 (HER2)] in ...
NK cell-related immunotherapeutics, such as tumor-specific monoclonal antibodies (mAbs) to elicit NK cell-mediated ADCC against tumor cells, are being developed for the treatment of cancers. As an ...
Complex biology cannot be modeled with simple, standalone in vitro systems. More sophisticated, physiologically relevant systems are needed. For example, systems that maintain cellular environments ...
Due to their diverse functions, antibodies (Abs) can fight viral infections on multiple fronts. For example, neutralizing antibodies (nAbs) can block viral entry into cells, whereas non-neutralizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results